Large-scale studies have not found that COVID-19 vaccines increase the risk of developing diabetes. Population-level data shows stable diabetes incidence rates before, during, and after mass vaccination campaigns. However, COVID-19 infection itself does appear to raise diabetes risk, and vaccination may actually reduce that particular danger.
What Large Studies Show
The most direct evidence comes from a study published in JAMA Network Open that compared diabetes risk in vaccinated and unvaccinated people after COVID-19 infection. Unvaccinated patients who caught COVID had a 78% higher odds of developing new diabetes compared to those who were never infected. Vaccinated patients who caught COVID showed only a 7% increase, which was so small it wasn’t statistically meaningful. In other words, vaccination appeared to blunt the diabetes risk that comes with infection rather than create new risk on its own.
A separate study tracking over 14 million registered residents in China between 2007 and 2021 looked specifically at Type 1 diabetes incidence before and after COVID vaccination rolled out. The rate of new Type 1 diabetes diagnoses remained stable from 2019 through 2021, the period when mass vaccination occurred. This held true across age groups, including children under 14 and young adults aged 15 to 29. The researchers concluded that COVID-19 vaccination did not increase the onset of Type 1 diabetes on a population level.
Why the Concern Exists
The worry isn’t baseless. The spike protein that mRNA vaccines teach your body to recognize can interact with a receptor called ACE2, which is found on insulin-producing beta cells in the pancreas. Lab research has shown that spike protein variants can stimulate metabolic activity in these cells, and that high blood sugar may make beta cells more susceptible to spike protein binding. This biological plausibility is what drives ongoing investigation, even though population data hasn’t confirmed a real-world problem.
There are also a small number of case reports describing individuals who developed diabetes shortly after vaccination. One published case involved a 69-year-old man with prediabetes (an HbA1c of 5.8%) whose blood sugar control deteriorated rapidly after mRNA vaccination. Within a year, his HbA1c had climbed to 13.7% and he presented with diabetic ketoacidosis, a dangerous complication. Testing revealed antibodies against his own insulin-producing cells, suggesting an autoimmune process consistent with Type 1 diabetes. He had no history of COVID-19 infection.
Cases like this are striking, but they represent isolated reports rather than a pattern. People develop Type 1 diabetes every day for reasons that aren’t always clear, and it’s difficult to prove that vaccination triggered the process rather than coinciding with it. The man already had prediabetes, and autoimmune diabetes can progress silently for months or years before symptoms appear.
Effects on People Who Already Have Diabetes
If you already live with diabetes, vaccination does not appear to cause lasting changes in blood sugar control. A systematic review found no significant abnormal fluctuations in blood glucose among diabetic patients after vaccination. One study followed 39 people with Type 1 diabetes through their full vaccination series and found no meaningful changes in time spent in target glucose range, average glucose levels, or daily insulin doses before versus after vaccination.
Some people with Type 1 diabetes did experience temporary blood sugar disturbances after getting vaccinated. This was more common in older patients and those taking both oral diabetes medications and insulin. These short-term fluctuations are consistent with the immune response that any vaccine triggers. Fever, inflammation, and stress hormones can all nudge blood sugar up for a day or two. This is a manageable side effect, not a sign of worsening disease.
COVID Infection Poses the Bigger Diabetes Risk
The clearer and more concerning link runs between COVID-19 infection and new diabetes, not between vaccination and diabetes. The virus itself can directly damage insulin-producing cells in the pancreas, trigger widespread inflammation, and provoke autoimmune reactions. Multiple large studies have documented increased rates of new diabetes diagnoses in the months following COVID infection, with unvaccinated individuals facing the highest risk.
The JAMA Network Open data is particularly telling here. The 78% increased diabetes risk seen in unvaccinated patients after infection dropped to a statistically insignificant level in vaccinated patients who got infected. This suggests vaccination may protect the pancreas indirectly by limiting how severely the virus affects the body.
What This Means in Practice
If you’re worried about diabetes risk specifically, the evidence points in one direction: COVID-19 infection is the threat, and vaccination reduces that threat. No large-scale study has identified an increase in diabetes rates attributable to COVID vaccines. The biological concern about spike protein and pancreatic cells exists in lab settings but hasn’t translated into detectable population-level harm.
If you have prediabetes or risk factors for diabetes, it’s worth knowing that rare case reports exist, even if they don’t establish a causal link. Monitoring your blood sugar after vaccination is reasonable, particularly if you’re already tracking it. But skipping vaccination to avoid a theoretical diabetes risk would, based on current evidence, leave you more exposed to the well-documented diabetes risk that comes with COVID-19 infection itself.